Raynaud phenomenon in dermatology.: Part 1:: Pathophysiology and diagnostic approach

被引:14
作者
Sunderkotter, C.
Riernelkasten, G.
机构
[1] Univ Klinikum Munster, Dermatol Klin & Poliklin, D-48129 Munster, Germany
[2] Univ Klin, Charite, Abt Rheumatol & Klin Immunol, Berlin, Germany
来源
HAUTARZT | 2006年 / 57卷 / 09期
关键词
Raynaud phenomenon; scleroderma; vascular damage; endothelin; capfllarosopy;
D O I
10.1007/s00105-006-1192-x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Raynaud phenomenon (RP) is characterized by recurrent spasms of small digital arterioles/arteries at fingers and toes, usually triggered by cold and emotional stress. Clinically a sudden pallor of individual digits is followed by reactive hyperemia, in severe cases also by cyanosis. One distinguishes between primary RP, i.e. RP without an underlying disease or drug intake, and secondary RIP, which is causally related to an underlying disease or to intake of certain drugs (e.g. interferon, cisplatin). Primary RP is frequent (prevalence of about 13-20% in northern or central Europe), while secondary RP is rare, but the major presenting symptom for systemic sclerosis (SSc). Differential diagnosis includes cold-induced pallor, acute embolic events, paroxysmal hematoma of the finger or erythromelalgia. Vasoconstrictive mechanisms outweigh vasodilatory ones in endothelial cells and vascular smooth muscle. Although soluble mediators such as endothelin or certain Prostaglandins have been exploited successfully for therapy, the extent of their involvement in the initial pathophysiology of RP is unclear. Secondary RP (associated with SSc) additionally features morphological alterations with compromise of the vessel lumen. As RP can result in severe discomfort and complications, timely diagnosis and treatment is essential.
引用
收藏
页码:819 / 828
页数:10
相关论文
共 35 条
[1]   Rho kinase mediates cold-induced constriction of cutaneous arteries -: Role of α2C-adrenoceptor translocation [J].
Bailey, SR ;
Eid, AH ;
Mitra, S ;
Flavahan, S ;
Flavahan, NA .
CIRCULATION RESEARCH, 2004, 94 (10) :1367-1374
[2]   Raynaud's phenomenon [J].
Block, JA ;
Sequeira, W .
LANCET, 2001, 357 (9273) :2042-2048
[3]  
Boin F, 2005, CURR OPIN RHEUMATOL, V17, P752
[4]  
Bukhari M, 1996, BRIT J RHEUMATOL, V35, P1127
[5]   DEFICIENCY OF CALCITONIN GENE-RELATED PEPTIDE IN RAYNAUDS-PHENOMENON [J].
BUNKER, CB ;
TERENGHI, G ;
SPRINGALL, DR ;
POLAK, JM ;
DOWD, PM .
LANCET, 1990, 336 (8730) :1530-1533
[6]   Silent α2C-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries [J].
Chotani, MA ;
Flavahan, S ;
Mitra, S ;
Daunt, D ;
Flavahan, NA .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2000, 278 (04) :H1075-H1083
[7]   EFFECTS OF BETA-ADRENORECEPTOR-BLOCKING DRUGS IN PATIENTS WITH RAYNAUD PHENOMENON [J].
COFFMAN, JD ;
RASMUSSEN, HM .
CIRCULATION, 1985, 72 (03) :466-470
[8]  
Flavahan NA, 2000, ARTHRITIS RHEUM-US, V43, P1886, DOI 10.1002/1529-0131(200008)43:8<1886::AID-ANR27>3.0.CO
[9]  
2-S
[10]   Cooling-induced contraction and protein tyrosine kinase activity of isolated arterioles in secondary Raynaud's phenomenon [J].
Furspan, PB ;
Chatterjee, S ;
Mayes, MD ;
Freedman, RR .
RHEUMATOLOGY, 2005, 44 (04) :488-494